Sunil Healthcare valuation

Share price at each year-end
Tap a line for its trendCurrentlast closeFY24Mar 2024
Price multiples — at each FY-end close
0.94×—
0.77×—
Enterprise multiples
1.51×—
33.25×—
−68.01×—
Yield
−2.6%—
−35.6%—
Reference — adjusted share basis
₹67.90—
−₹1.74−₹1.74
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SUNLOC₹67.90

Sunil Healthcare Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARMcap ₹69.8 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY24
31/03/2024
Current
last close
Price Multiples — at each FY-end close
P/B—0.94
P/Sales—0.77
Enterprise Multiples
EV/Sales—1.51
EV/EBITDA—33.25
EV/EBIT—-68.01
Yield
Earnings Yield %—-2.56
FCF Yield %—-35.55
Reference — adjusted share basis
Price (FY-end close, adj.)—67.90
EPS (adj.)-1.74-1.74
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.